
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic therapies for HS, emphasizing individualized patient selection and timing of intervention.

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic therapies for HS, emphasizing individualized patient selection and timing of intervention.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed clinical cases highlighting the distinct roles of topical ruxolitinib, tapinarof, and roflumilast in managing itch, inflammation, and long-term disease control in atopic dermatitis.

Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.

Catch up on coverage from this year's Winter Clinical Miami meeting.

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.

At Winter Clinical Miami 2026, Andrew F. Alexis, MD, MPH, shares skin-of-color therapy pearls as Clay Cockerell, MD, spotlights must-biopsy mimickers.

Winter Clinical Miami experts shared professional development tips and clinical pearls during the meeting's classic "15 Tips in 15 Minutes" session.

Omar Noor, MD, shares pearls on type 2 inflammation, including dupilumab insights for atopic dermatitis, prurigo nodularis, and CSU at Horizons in Advanced Practice.

Nicholas Brownstone, MD, and other experts spotlighted cytokine hubs at the 2026 Winter Clinical Miami conference, linking chronic spontaneous urticaria and psoriasis/psoriatic arthritis to smarter targeted treatment choices.

Explore top dermatology conferences and meetings in March 2026 and let us know which ones you'll be attending!

CLEAR CSCC is evaluating whether low-dose intralesional cemiplimab is noninferior to primary surgery, potentially offering a tissue-sparing alternative to standard surgical management.

Brian Berman, MD, PhD, explains actinic keratosis-to-SCC risk and newer PDT/field therapies that improve clearance with less pain.

Ruiz Dasilva emphasized case-based strategies for managing complex inflammatory dermatoses, highlighted chronic pruritus as an urgent unmet need, and called for more standardized designs for atopic dermatitis trials.

Terrence Keaney, MD, and Dawn Merritt, DO, discuss AI workflows and smart practice systems—plus how a dermatology niche drives referrals and growth.

James Del Rosso, DO, shares rapid-fire insights on mentorship, HS advances, contact dermatitis triggers, and teen skin care marketing concerns.

Catch up on coverage from the final day of Winter Clinical Miami 2026.

Rapid-fire WCM tips included off-label treatment strategies, AI-driven practice management tools, and patient optimization methods.

Real-world data shows Medicare plaque psoriasis patients stay on Sun Pharma’s IL-23 tildrakizumab longer than other systemic therapies.

At Winter Clinical Miami, Lisa Swanson, MD, FAAD, shared practical, prior authorization–free treatment strategies while calling for expanded therapeutic options and earlier research inclusion for children under 12.

At Winter Clinical Miami 2026, Lewitt and Goldenberg share contract, workflow, and ethical industry tips every early career derm needs to thrive.

Nicholas Brownstone, MD, showcased multidisciplinary collaboration and educational podcast initiatives aimed at supporting both dermatology trainees and patients.

Catch up on coverage from the second day of Winter Clinical Miami 2026.

Harrison Nguyen, MD, MBA, MPH, FAAD, shares early career billing, coding, and mentorship tips for dermatologists at Winter Clinical Miami 2026.

A Winter Clinical Miami poster highlights intralesional cemiplimab for early CSCC, showing rapid responses and positive safety versus surgery.

At Winter Clinical Miami 2026, Linda Stein Gold, MD, FAAD, shared acne and rosacea tips and previewed psoriasis oral advances like icotrokinra.

At Winter Clinical Miami 2026, April Armstrong, MD, MPH, spotlights new pediatric topicals and JAK safety insights, plus targeted options for head-and-neck atopic dermatitis.

A poster presented at Winter Clinical Miami 2026 shows tildrakizumab is often preferred for older patients with plaque psoriasis and medically complex comorbidities.

Catch up on coverage from the first day of Winter Clinical Miami 2026.

Mark Lebwohl, MD, shares his Winter Clinical Miami 2026 highlights, including oral psoriasis peptides, atopic dermatitis advances, GLP-1 combos, and more.

Winter Clinical Miami 2026 speakers share buy-and-bill and real estate tactics for dermatologists to boost revenue and protect cash flow.